KAT-681 is a liver-selective thyromimetic. References: Hayashi M, Ohnota H, Tamura T, Kuroda J, Shibata N, Akahane M, Moriwaki H, Machida N, Mitsumori K. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation. Arch Toxicol. 2004 Aug;78(8):460-6. Epub 2004 Mar 19. PubMed PMID: 15034639.

纯度：≥98%

CAS：373641-87-3